Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.

J Clin Pathol · 2015 · PMC4602233 · PMID 26251520

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendp=0.09so close (0.05 < p ≤ 0.1)

Additionally, grading 49 showed a trend for reduced PFS (p=0.09).

also in 53,322 other papers

highly significantno p-value reported

In multivariable Cox regression models, Cx43 immunoreactivity and histological growth pattern remained highly significant and adverse risk factors for PFS.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.